Calcium (Ca) is a critical regulator of cardiomyocyte contractile function. Cardiac excitation contraction (EC) coupling requires activation of the Ca release channel/ryanodine receptor (RyR2) in the sarcoplasmic reticulum (SR) by signals transmitted via the voltage-gated Ca channel/dihydropyridine receptor (DHPR) in the transverse (T) tubule. Altered a homeostasis due to an as yet unidentified defect in EC coupling has been proposed as a possible contributory factor to the pathogenesis of heart failure. In the failing heart a defect in Ca signaling could result from a number of abnormalities including one or more of the following: 1) changes in the expression of Ca handling proteins; 2) post-translational modifications of Ca handling proteins; 3) anatomical changes in cardiomyocytes and/or extracellular matrix; 4) decreased myofilament responsiveness to Ca. To establish that a defect in any of the above is causal in the pathogenesis of heart failure, it is necessary to demonstrate that introducing the defect in Ca signaling can cause heart failure or correcting the defect can restore normal cardiac function. The goal of this proposal is to identify specific molecular defect(s) in Ca handling that contribute to the pathogenesis of heart failure. The investigators have access to a unique human model of heart failure: human myocardium from pre- (dysfunctional) and post- (normal function) left ventricular assist device (LVAD) implantation patients. Animal models of heart failure that are physiologically relevant to human heart failure have been developed to test hypothesis regarding the etiology of contractile dysfunction in the failing heart. The investigators propose:
Aim 1 to use pre- (failing) and post-LVAD (normalized function) myocardial samples to obtain data comparing Ca signaling and EC coupling in normalized and failing myocardium obtained from the same patient;
Aim 2 to use well defined animal models of heart failure to analyze Ca signaling and EC coupling during the progression of heart failure at four levels: 1) isolated functional systems (including RyR2 single channel properties), 2) integrated cellular function (including Ca transients), 3) biochemical studies examining the levels of expression (mRNA and protein) of Ca handling molecules;
Aim 3 to test the hypothesis that a defect in activation of RyR2 is present in cardiomyocytes from failing hearts compared to cardiomyocytes from normal hearts and to induce defects in EC coupling in cardiomyocytes from normal hearts and to induce defects in EC coupling in cardiomyocytes by transfecting mutant RyR2 channels and by overexpressing IP3 receptors and to determine whether specific molecular defects can cause altered Ca handling, defective EC coupling and heart failure in transgenic mice.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL061503-02
Application #
6078040
Study Section
Special Emphasis Panel (ZHL1-CSR-F (S1))
Project Start
1998-09-30
Project End
2003-09-29
Budget Start
1999-09-30
Budget End
2000-09-29
Support Year
2
Fiscal Year
1999
Total Cost
Indirect Cost
Name
Columbia University (N.Y.)
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
167204994
City
New York
State
NY
Country
United States
Zip Code
10032
Kushnir, Alexander; Santulli, Gaetano; Reiken, Steven R et al. (2018) Ryanodine Receptor Calcium Leak in Circulating B-Lymphocytes as a Biomarker in Heart Failure. Circulation 138:1144-1154
Hartel, Andreas J W; Ong, Peijie; Schroeder, Indra et al. (2018) Single-channel recordings of RyR1 at microsecond resolution in CMOS-suspended membranes. Proc Natl Acad Sci U S A 115:E1789-E1798
Santulli, Gaetano; Lewis, Daniel; des Georges, Amedee et al. (2018) Ryanodine Receptor Structure and Function in Health and Disease. Subcell Biochem 87:329-352
Lacampagne, Alain; Liu, Xiaoping; Reiken, Steven et al. (2017) Post-translational remodeling of ryanodine receptor induces calcium leak leading to Alzheimer's disease-like pathologies and cognitive deficits. Acta Neuropathol 134:749-767
Bussiere, Renaud; Lacampagne, Alain; Reiken, Steven et al. (2017) Amyloid ? production is regulated by ?2-adrenergic signaling-mediated post-translational modifications of the ryanodine receptor. J Biol Chem 292:10153-10168
Zalk, Ran; Marks, Andrew R (2017) Ca2+ Release Channels Join the 'Resolution Revolution'. Trends Biochem Sci 42:543-555
Santulli, Gaetano; Lewis, Daniel R; Marks, Andrew R (2017) Physiology and pathophysiology of excitation-contraction coupling: the functional role of ryanodine receptor. J Muscle Res Cell Motil 38:37-45
Yuan, Qi; Yang, Jingyi; Santulli, Gaetano et al. (2016) Maintenance of normal blood pressure is dependent on IP3R1-mediated regulation of eNOS. Proc Natl Acad Sci U S A 113:8532-7
des Georges, Amédée; Clarke, Oliver B; Zalk, Ran et al. (2016) Structural Basis for Gating and Activation of RyR1. Cell 167:145-157.e17
Zalk, Ran; Clarke, Oliver B; des Georges, Amédée et al. (2015) Structure of a mammalian ryanodine receptor. Nature 517:44-9

Showing the most recent 10 out of 49 publications